Showing results (1211-1220 of 2,583) with videos related to

Sort By:
Pageof 259
Molecular Oncology|May 21, 2024
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencingTerezia Kurucova, Kamila Reblova, Pavlina Janovska, et al.
Molecular Oncology|May 17, 2024
Benign breast tumors may arise on different immunological backgroundsLilly Anne Torland, Xiaoran Lai, Surendra Kumar, et al.
Molecular Oncology|May 10, 2024
Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signaturesAna Glenda Santarosa Vieira, Luciane Sussuchi da Silva, Eduardo Caetano Albino da Silva, et al.
Molecular Oncology|April 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancerThomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, et al.
Molecular Oncology|May 7, 2024
Microglia and macrophages in glioblastoma: landscapes and treatment directionsGeorgios Solomou, Adam M H Young, Harry J C J Bulstrode
Molecular Oncology|November 13, 2023
Hyaluronic acid metabolism and chemotherapy resistance: recent advances and therapeutic potentialZhanhong Liu, Pengbo Hou, Jiankai Fang, et al.
Molecular Oncology|November 9, 2023
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implicationsSara Hijazo-Pechero, Ania Alay, David Cordero, et al.
Molecular Oncology|November 20, 2023
FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signalingMarion Morel, Weiwen Long
Molecular Oncology|October 16, 2023
Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistanceYao-Yu Hsieh, Jia-Ling Du, Pei-Ming Yang
Molecular Oncology|September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapyGoran Rac, Hiten D Patel, Christopher James, et al.
Pageof 259